SCHEMBL4869269

SCHEMBL4869269

CC[C@H]1C(=O)N(C)c2cc(F)ccc2N1S(=O)(=O)c1ccc(O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.42
BRD4 O60885 2/20 0.40
PSEN1 P49768 5/20 0.36
PSEN2 P49810 5/20 0.36
APH1B Q8WW43 5/20 0.36
NCSTN Q92542 5/20 0.36
APH1A Q96BI3 5/20 0.36
PSENEN Q9NZ42 5/20 0.36
ESR1 P03372 1/20 0.35
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
CMA1 P23946 1/20 0.33
PLK1 P53350 1/20 0.33
PLK2 Q9NYY3 1/20 0.33
HTR6 P50406 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4867899 0.95 BRD4 (0.42) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4863631 0.88 PARK7 (0.42) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4860885 0.87 HSD11B1 (0.42) MMP2BRD4KMT2A
SCHEMBL4871661 0.86 MMP2 (0.42) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4867578 0.86 MMP2 (0.40) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4869264 0.85 PARK7 (0.42) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4863678 0.84 MMP2 (0.38) MMP2PSEN1PSEN2APH1BNCSTN
SCHEMBL4869258 0.83 BRD4 (0.50) MMP2BRD4ESR1MEN1CYP1A2
SCHEMBL4867915 0.82 BRD4 (0.42) MMP2BRD4PSEN1PSEN2APH1B
SCHEMBL4871154 0.81 MMP2 (0.50) MMP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US claimed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US claimed
US-7351709-B2 Estrogen receptor ligands WYETH (US) 2008-04-01 US disclosed
US-20060019961-A1 Estrogen receptor ligands WYETH 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019961-A1 Estrogen receptor ligands GPER1, ESR2, ESR1 MMP2 2599/4885BRD4 1413/4885PSEN1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.